Key result
Baroreceptor activation therapy in HFrEF requires careful patient selection based on CRT status to optimize outcomes.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May support CRT-based selection for baroreceptor activation therapy in HFrEF; hypothesis-generating and requires prospective validation.
This article refers to 'Baroreflex Activation Therapy for the Treatment of Heart Failure with a Reduced Ejection Fraction: Safety and Efficacy in Patients with and without Cardiac Resynchronization Therapy', by Zile MR et al.
No takes yet. Share an insight, caveat, or question.
Mortara et al. (2015) studied this question. Baroreceptor activation therapy for heart failure with reduced ejection fraction requires careful patient selection to optimize outcomes based on cardiac resynchronization therapy status.
Synapse has enriched 10 related papers. Consider them for comparative context: